EX-16 2 a07-19495_1ex16.htm EX-16

Exhibit 16

July 16, 2007

U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, NE
Washington, DC  20549

Re:

 

USANA Health Sciences, Inc.

 

 

File No. 0-21116

 

Dear Sir or Madam:

We have read Item 4.01 of Form 8-K of USANA Health Sciences, Inc. dated July 16, 2007, and agree with the statements concerning our Firm contained therein.

Very truly yours,

/s/ Grant Thornton LLP

 

GRANT THORNTON LLP